ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with chronic heart failure
ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with chronic heart failure
复制标题
DOI：
10.1161/circulationaha.105.170073
复制
发表时间：
2005-09-20
期刊：
影响因子：
37.8
通讯作者：
Redberg, RF
中科院分区：
文献类型：
--
作者：
Radford, MJ;Arnold, JMO;Redberg, RF
心力衰竭（HF）综合征是包括冠状动脉疾病、高血压、瓣膜疾病和原发性心肌疾病在内的各种心血管疾病的晚期的常见表现。它是老年人住院治疗的最常见原因（1），它的出现通常预示着需要在患者的一生中进行持续的护理。HF的治疗受益于对疾病基本分子机制的科学研究（2，3），工程、仪器和手术的进步（4）以及大型多中心试验（5-7）和登记研究（8，9）。越来越多的HF患者，特别是晚期HF患者的护理可以在专业诊所采用团队方法进行（10-12）。此外，国家对治疗质量的兴趣日益增长，已将重点放在对HF护理模式和结局的审查上（13，14）。ACC和AHA确定心力衰竭为数据标准的制定对象。与第一种情况急性冠状动脉综合征（ACS）（15）和第二种情况房颤（AF）（16）一样，数据标准的目标是提供一个标准化的信息平台，在各种情况下都很有用，特别是临床试验、临床登记和质量性能测量。与ACS和AF临床数据标准编写委员会类似，ACC/AHA心力衰竭临床数据标准编写委员会继续开发数据元素定义，并理解它们在各种情况下可能有用：
The syndrome of heart failure (HF) is a common manifestation of the later stages of various cardiovascular diseases, including coronary artery disease, hypertension, valvular disease, and primary myocardial disease. It is the most common reason for hospitalization among older individuals (1), and its appearance usually foreshadows the need for ongoing care for the duration of the patient’s life. Therapy for HF has benefited from scientific investigations into basic molecular mechanisms of disease (2, 3) from advances in engineering, instrumentation, and surgery (4) and from large multicenter trials (5–7) and registries (8, 9). Increasingly, care of patients with HF, particularly advanced HF, may take place in specialized clinics using a team approach (10–12). In addition, growing national interest in quality of treatment has focused scrutiny on patterns and outcomes of HF care (13, 14).Heart failure was identified for development of data standards by the ACC and the AHA. As with the first condition, acute coronary syndromes (ACS)(15), and the second condition, atrial fibrillation (AF)(16), the goal of the data standards is to provide a standardized information platform that will be useful in a variety of situations, particularly clinical trials, clinical registries, and quality performance measurement. Similar to the writing committees for ACS and AF clinical data standards, the ACC/AHA Writing Committee to Develop Clinical Data Standards for Heart Failure proceeded to develop data element definitions with the understanding that they might be useful in a variety of circumstances: